Beijing Tiantan Biological Products (SHSE:600161) Change In Payables And Accrued Expense : ¥0 Mil (TTM As of Mar. 2025)

View and export this data going back to 1998. Start your Free Trial

What is Beijing Tiantan Biological Products Change In Payables And Accrued Expense?

Beijing Tiantan Biological Products's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2025 was ¥0 Mil. It means Beijing Tiantan Biological Products's Accounts Payable & Accrued Expense stayed the same from Dec. 2024 to Mar. 2025 .

Beijing Tiantan Biological Products's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2024 was ¥0 Mil. It means Beijing Tiantan Biological Products's Accounts Payable & Accrued Expense stayed the same from Dec. 2023 to Dec. 2024 .

Beijing Tiantan Biological Products Change In Payables And Accrued Expense Historical Data

The historical data trend for Beijing Tiantan Biological Products's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Tiantan Biological Products Change In Payables And Accrued Expense Chart

Beijing Tiantan Biological Products Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

Beijing Tiantan Biological Products Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-	-	-	-	-

Beijing Tiantan Biological Products Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

Beijing Tiantan Biological Products Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Beijing Tiantan Biological Products's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Tiantan Biological Products Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Tiantan Biological Products Corp Ltd (SHSE:600161) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 6, Boxing 2nd Road, Room 521, Building 8, Beijing Economic and Technological Development Zone, Beijing, CHN, 100024

Website

https://www.tiantanbio.com

Beijing Tiantan Biological Products Corp Ltd uses healthy human plasma and specifically immunized human plasma as raw materials and adopts genetic recombination technology to develop and produce blood products and engage in the blood product business.

Executives

Zhang Yi	senior management
Ci Xiang	senior management
Fu Dao Xing	Directors, senior managers
Hu Li Gang	Director
Yang Hui Chuan	Director
Liu Ya Na	Directors, senior managers
He Yan Lin	Directors, senior managers
Wang Jian Ming	Supervisors
Wu Zhen Shan	senior management

Beijing Tiantan Biological Products Headlines

No Headlines